Fulgent Genetics to Acquire Bako Diagnostics and StrataDx

Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)

October 4, 2022

Biotechnology

Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.

LabGenomics USA LLC Acquires QDx Pathology

September 5, 2023

Healthcare Services

LabGenomics USA LLC, a subsidiary of South Korea–based LabGenomics Co., Ltd., has acquired QDx Pathology, a U.S. clinical and molecular pathology laboratory. The deal, signed in August 2023, is intended to accelerate LabGenomics' entry and expansion into the North American diagnostics market by combining QDx's lab services with LabGenomics' NGS-based molecular diagnostics capabilities.

Fulgent Genetics Acquires Inform Diagnostics from Avista Capital Partners

April 18, 2022

Healthcare Services

Fulgent Genetics (NASDAQ: FLGT) closed its acquisition of Inform Diagnostics, a national independent pathology laboratory headquartered in Irving, Texas, for approximately $170 million (subject to adjustments). Avista Capital Partners had carved out and grown Inform Diagnostics before selling it to Fulgent, enabling Fulgent to expand into pathology test menus and nationwide commercial infrastructure.

Fulgent Genetics Acquires Fulgent Pharma

November 7, 2022

Biotechnology

Fulgent Genetics completed the acquisition of Fulgent Pharma Holdings for approximately $100 million in a combination of cash and Fulgent common stock. The deal integrates Fulgent Pharma’s nanoencapsulation drug-delivery platform and clinical-stage oncology pipeline with Fulgent Genetics’ diagnostics capabilities to create a vertically integrated precision-medicine offering focused on cancer.

GeneDx to Acquire Fabric Genomics

May 7, 2025

Healthcare Services

GeneDx announced it would acquire Fabric Genomics, an AI-powered genomic interpretation platform company, to enable decentralized testing powered by centralized intelligence. The deal expands GeneDx’s capabilities in NICU genomic testing and genomic newborn screening and targets global delivery of genomic insights.

Bionano Genomics Acquires BioDiscovery

October 12, 2021

Software

Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.